Artiva Biotherapeutics In...
(ARTV)
undefined
undefined%
At close: undefined
10.62
0.95%
After-hours Dec 13, 2024, 04:00 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Cash & Equivalents | 53.50M | 102.53M | 160.92M | 25.44M | 3.77M |
| Short-Term Investments | 23.47M | - | - | - | - |
| Long-Term Investments | - | - | - | - | - |
| Other Long-Term Assets | 650.00K | 762.00K | 3.56M | 732.00K | - |
| Receivables | 1.76M | 525.00K | 468.00K | - | - |
| Inventory | - | - | - | - | - |
| Other Current Assets | 1.09M | 1.62M | 896.00K | 666.00K | 90.00K |
| Total Current Assets | 79.82M | 104.67M | 162.29M | 26.11M | 3.77M |
| Property-Plant & Equipment | 24.64M | 27.61M | 4.08M | 2.39M | - |
| Goodwill & Intangibles | - | - | - | - | - |
| Total Long-Term Assets | 25.29M | 28.37M | 7.64M | 3.13M | - |
| Total Assets | 105.11M | 133.05M | 169.93M | 29.23M | - |
| Account Payables | 614.00K | 1.10M | 1.44M | 2.15M | 258.00K |
| Deferred Revenue | - | 10.89M | 7.29M | - | - |
| Short-Term Debt | 3.60M | 3.49M | 433.00K | 458.00K | 208.00K |
| Other Current Liabilities | 8.02M | 10.15M | 10.13M | 3.15M | 476.00K |
| Total Current Liabilities | 12.23M | 25.63M | 19.30M | 5.76M | - |
| Long-Term Debt | 13.32M | 15.96M | 1.31M | 1.66M | 7.61M |
| Other Long-Term Liabilities | 241.59M | 115.00K | 81.00K | 43.38M | 245.00K |
| Total Long-Term Liabilities | 254.90M | 248.13M | 239.48M | 45.04M | - |
| Total Liabilities | 267.13M | 273.75M | 258.78M | 50.80M | - |
| Total Debt | 16.91M | 19.45M | 1.74M | 2.12M | - |
| Common Stock | - | - | - | - | - |
| Retained Earnings | -181.31M | -152.59M | -93.80M | -21.98M | - |
| Comprehensive Income | 308.00K | - | - | - | - |
| Shareholders Equity | -162.01M | -140.70M | -88.86M | -21.57M | - |
| Total Investments | 23.47M | - | - | - | - |